Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
February, 2026
February 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
232425262728  
For People on Emicizumab, the Use of a aPCC Raises Critical Clinical Questions
World Federation of Hemophilia/LinkedIn
Oct 30, 2025, 06:57

For People on Emicizumab, the Use of a aPCC Raises Critical Clinical Questions

World Federation of Hemophilia shared a post on LinkedIn:

“For people on emicizumab, the use of activated prothrombin complex concentrate (aPCC) raises critical clinical questions. A new article bridges evidence with real-world practice to guide safer, smarter care decisions.”

Title: Activated prothrombin complex concentrate in patients receiving emicizumab prophylaxis: from evidence to clinical practice

Authors: Robert F. Sidonio, Jr., Guy Young, Carmen Escuriola Ettingshausen, Johnny Mahlangu, Margareth C. Ozelo, Alok Srivastava, Jerzy Windyga, Hye–Youn Lee, Aurelia Lelli, Steven W. Pipe

For People on Emicizumab, the Use of a aPCC Raises Critical Clinical Questions

 

Read full article here.

Stay informed with Hemostasis Today.

activated prothrombin complex concentrate (aPCC) Alok Srivastava Aurelia Lelli Carmen Escuriola Ettingshausen Emicizumab Guy Young Health Hematology Hemostasis Hemostasis Today Hye–Youn Lee Jerzy Windyga Johnny Mahlangu Jr. Margareth C. Ozelo Medicine Robert F. Sidonio rpth Steven W. Pipe World Federation of Hemophilia
NewsFeed